ICYMI: Celebrating 10 Years of Cancer Research News – NCI Cancer Currents

Catch up on the latest news and research updates from the National Cancer Institute.

Celebrating 10 Years of Cancer Research News It's been 10 years and about 800 stories. More keystrokes have been tapped, story drafts revised, and jargon-filled scientific papers pored over than anybody cares to count. There have been stories on advances in immunotherapy and targeted therapies, cancer's complex biological underbelly, preventing and treating side effects, and much more. To mark our 10th anniversary, we've gathered a collection of our past stories that capture what Cancer Currents is all about: Bringing the cancer community scientifically accurate and meaningful news stories, often with the perspective of experts at NCI, about the research we're all counting on to save more lives from cancer. We've picked a few stories from each year to share. Some of these stories reported paradigm-changing findings, while others described the first hints of something big on the horizon, or discussed important issues and topics that may not get the attention they deserve. So, as we begin a new year, we hope you enjoy this trip through recent cancer research history, and thanks for being part of our 10 years as a trusted source of cancer news. Carmen Phillips Managing Editor, Cancer Currents 2015 The RAS Problem: Turning Off a Broken Switch FDA Approves First Therapy for High-Risk Neuroblastoma Treatment Helps Preserve Fertility for Some Women with Breast Cancer 2016 Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor Biopsy Prospective Study Links HPV Detection in the Mouth to Head and Neck Cancer Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer 2017 CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia Colorectal Cancer Incidence Rising in Young Adults: An Interview with Drs. Philip Rosenberg and William Anderson An Important Moment in Tobacco Control 2018 Sodium Thiosulfate Prevents Cisplatin-Induced Hearing Loss in Some Children Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations For Small Cell Lung Cancer, Immunotherapy Drug Finally Brings Improved Survival 2019 Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain Multipronged Approach Eliminates Racial Disparities in Early-Stage Lung Cancer Treatment Osimertinib Improves Survival in Advanced Lung Cancer with EGFR Mutations 2020 PSMA PET-CT Accurately Detects Prostate Cancer Spread, Trial Shows Persistent Poverty Linked to Increased Risk of Dying from Cancer Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types 2021 Addressing the Challenges of Cancer Misinformation on Social Media Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer NF1 Associated with More Cancer Types Than Previously Known 2022 For Some Kids with Brain Cancer, Targeted Therapy Is Better than Chemo For Early-Stage Lung Cancer, Nivolumab and Chemo before Surgery Proves Effective Severe Side Effects of Cancer Treatment Are More Common in Women than Men 2023 Immunotherapy and… Nothing Else? Studies Test Potential Paradigm Shift in Cancer Treatment Pausing Long-Term Breast Cancer Therapy to Become Pregnant Appears to Be Safe Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder Cancer 2024 Drug Combination May Have Potential for Cancers with TP53 Mutations First Cancer TIL Therapy Gets FDA Approval for Advanced Melanoma Will Ponsegromab Be a Game Changer for Cancer Cachexia? To read more news and research updates from the National Cancer Institute, visit the Cancer Currents blog.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892